Having been renamed several times, until 2016 the firm was dba as StemCells (NASDAQ:STEM). In Novermber 2016 - in some trouble, the firm did a reverse merger with privately held, Israeli firm MicroBot Medical and now trades under that name (NASDAQ:MBOT). Where the orginal StemCells had been organized around cell-based therapeutics and related technologies for stem cell-based research and drug discovery and development: stem cell therapies and encapsulated cell therapies. With a total personnel restructure, the new entity dba Microbot Medical and is a medical device company specializing in the design and development of transformational micro-robotic medical technologies, primarily focused on leveraging its micro-robotic technologies with the goal of allowing more physicians to treat more patients while improving surgical outcomes for patients. With its HQ and faciliites in Hingham, MA the firm's first two product candidates: the Self Cleaning Shunt, or SCS, for the treatment of hydrocephalus and Normal Pressure Hydrocephalus, or NPH; and TipCAT, a self-propelling, semi-disposable endoscope that is being developed initially for use in colonoscopy procedures.
